Shreehas Tambe serves as the CEO and Managing Director of Biocon Limited. He has been instrumental in transforming Biocon Biologics from a science and operations-focused entity into a fully integrated, lab-to-patient global biosimilars enterprise. With 28 years at Biocon, he has shaped the company's operating model across Commercial, R&D, Manufacturing, and Global Markets, establishing scalable capabilities and systems for long-term competitiveness.